Bausch Health has struck a deal to…
Bausch Health has struck a deal to buy Durect for [...]
After assuring investors last week…
After assuring investors last week that beleaguered Sarepta Therapeutics would [...]
After months of searching for…
After months of searching for strategic options, Adaptimmune is offloading [...]
MapLight Therapeutics has raised a…
MapLight Therapeutics has raised a $372.5 million series D round, [...]
Chinese biotech Leads Biolabs has…
Chinese biotech Leads Biolabs has hit the Hong Kong stock [...]
Bristol Myers Squibb has raided…
Bristol Myers Squibb has raided AstraZeneca to find its next [...]
The uncertainty around the future…
The uncertainty around the future of Elevidys hasn’t destroyed Roche’s [...]
A phase 2 trial of Memo…
A phase 2 trial of Memo Therapeutics’ kidney transplant drug [...]
Ikena and Inmagene have selected…
Ikena and Inmagene have selected Kristin Yarema, Ph.D., to lead [...]
Eli Lilly is walking through the…
Eli Lilly is walking through the Gate, inking a deal [...]